Amedisys Stock Retained Earnings

AMED Stock

USD 90.78 0.18 0.20%

Amedisys fundamentals help investors to digest information that contributes to Amedisys' financial success or failures. It also enables traders to predict the movement of Amedisys Stock. The fundamental analysis module provides a way to measure Amedisys' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Amedisys stock.

	Last Reported	Projected for Next Year
Retained Earnings	747.9 M	785.3 M
Retained Earnings Total Equity	871.3 M	914.9 M

The current year's Retained Earnings is expected to grow to about 785.3 M. The current year's Retained Earnings Total Equity is expected to grow to about 914.9 M.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Amedisys Company Retained Earnings Analysis

Amedisys' Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.

Retained Earnings

Beginning RE + Income

-

Dividends

More About Retained Earnings | All Equity Analysis

Current Amedisys Retained Earnings

747.92 M

Most of Amedisys' fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Amedisys is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Amedisys Retained Earnings Driver Correlations

Understanding the fundamental principles of building solid financial models for Amedisys is extremely important. It helps to project a fair market value of Amedisys Stock properly, considering its historical fundamentals such as Retained Earnings. Since Amedisys' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Amedisys' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Amedisys' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Current Deferred Revenue	Common Stock	Long Term Debt	Treasury Stock	Property Plant Equipment	Good Will	Intangible Assets	Net Tangible Assets	Total Permanent Equity	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.99	0.9	0.95	0.6	0.95	0.99	0.95	0.9	0.76	0.53	0.94	-0.92	-0.24	0.98	0.89	-0.81	0.29	0.88	0.85	0.4	0.72	0.8	0.91	-0.64	0.81
Total Stockholder Equity	0.99		0.86	0.93	0.64	0.97	0.97	0.95	0.88	0.76	0.58	0.92	-0.9	-0.24	0.97	0.88	-0.75	0.27	0.84	0.85	0.35	0.71	0.79	0.88	-0.62	0.79
Net Debt	0.9	0.86		0.9	0.56	0.78	0.91	0.74	0.83	0.63	0.37	0.98	-0.88	-0.17	0.92	0.91	-0.87	0.34	0.9	0.76	0.5	0.76	0.62	0.94	-0.56	0.65
Retained Earnings	0.95	0.93	0.9		0.47	0.87	0.94	0.85	0.87	0.81	0.29	0.94	-0.95	-0.37	0.98	0.88	-0.92	0.49	0.94	0.81	0.63	0.78	0.81	0.95	-0.66	0.84
Accounts Payable	0.6	0.64	0.56	0.47		0.66	0.58	0.56	0.43	0.13	0.78	0.52	-0.59	-0.05	0.57	0.72	-0.33	0.07	0.26	0.69	0.06	0.31	0.08	0.51	-0.6	0.17
Net Receivables	0.95	0.97	0.78	0.87	0.66		0.93	0.98	0.84	0.7	0.61	0.84	-0.88	-0.3	0.92	0.84	-0.68	0.34	0.76	0.86	0.34	0.66	0.76	0.8	-0.64	0.76
Total Liab	0.99	0.97	0.91	0.94	0.58	0.93		0.93	0.9	0.73	0.49	0.95	-0.91	-0.23	0.98	0.89	-0.84	0.31	0.89	0.84	0.44	0.69	0.79	0.92	-0.67	0.81
Total Current Assets	0.95	0.95	0.74	0.85	0.56	0.98	0.93		0.85	0.73	0.57	0.82	-0.83	-0.3	0.9	0.78	-0.66	0.29	0.76	0.82	0.3	0.63	0.82	0.78	-0.58	0.81
Short Term Debt	0.9	0.88	0.83	0.87	0.43	0.84	0.9	0.85		0.74	0.33	0.85	-0.75	-0.06	0.87	0.77	-0.72	0.32	0.84	0.65	0.36	0.61	0.8	0.83	-0.49	0.81
Current Deferred Revenue	0.76	0.76	0.63	0.81	0.13	0.7	0.73	0.73	0.74		0.16	0.71	-0.68	-0.4	0.76	0.56	-0.66	0.27	0.81	0.59	0.37	0.75	0.9	0.74	-0.22	0.85
Common Stock	0.53	0.58	0.37	0.29	0.78	0.61	0.49	0.57	0.33	0.16		0.39	-0.42	0.12	0.42	0.57	-0.08	-0.25	0.14	0.67	-0.26	0.34	0.17	0.36	-0.36	0.28
Long Term Debt	0.94	0.92	0.98	0.94	0.52	0.84	0.95	0.82	0.85	0.71	0.39		-0.89	-0.23	0.96	0.91	-0.88	0.33	0.95	0.79	0.47	0.79	0.74	0.96	-0.54	0.74
Treasury Stock	-0.92	-0.9	-0.88	-0.95	-0.59	-0.88	-0.91	-0.83	-0.75	-0.68	-0.42	-0.89		0.42	-0.96	-0.89	0.89	-0.52	-0.85	-0.9	-0.68	-0.76	-0.68	-0.91	0.78	-0.74
Property Plant Equipment	-0.24	-0.24	-0.17	-0.37	-0.05	-0.3	-0.23	-0.3	-0.06	-0.4	0.12	-0.23	0.42		-0.34	-0.19	0.45	-0.54	-0.35	-0.41	-0.61	-0.25	-0.37	-0.3	0.36	-0.37
Good Will	0.98	0.97	0.92	0.98	0.57	0.92	0.98	0.9	0.87	0.76	0.42	0.96	-0.96	-0.34		0.91	-0.89	0.4	0.92	0.86	0.54	0.75	0.79	0.95	-0.68	0.81
Intangible Assets	0.89	0.88	0.91	0.88	0.72	0.84	0.89	0.78	0.77	0.56	0.57	0.91	-0.89	-0.19	0.91		-0.82	0.34	0.81	0.9	0.43	0.79	0.58	0.94	-0.63	0.68
Net Tangible Assets	-0.81	-0.75	-0.87	-0.92	-0.33	-0.68	-0.84	-0.66	-0.72	-0.66	-0.08	-0.88	0.89	0.45	-0.89	-0.82		-0.57	-0.93	-0.73	-0.78	-0.71	-0.69	-0.93	0.66	-0.73
Total Permanent Equity	0.29	0.27	0.34	0.49	0.07	0.34	0.31	0.29	0.32	0.27	-0.25	0.33	-0.52	-0.54	0.4	0.34	-0.57		0.44	0.37	0.81	0.33	0.32	0.41	-0.5	0.33
Long Term Debt Total	0.88	0.84	0.9	0.94	0.26	0.76	0.89	0.76	0.84	0.81	0.14	0.95	-0.85	-0.35	0.92	0.81	-0.93	0.44		0.71	0.59	0.79	0.85	0.94	-0.47	0.85
Capital Surpluse	0.85	0.85	0.76	0.81	0.69	0.86	0.84	0.82	0.65	0.59	0.67	0.79	-0.9	-0.41	0.86	0.9	-0.73	0.37	0.71		0.46	0.75	0.62	0.85	-0.71	0.73
Deferred Long Term Liab	0.4	0.35	0.5	0.63	0.06	0.34	0.44	0.3	0.36	0.37	-0.26	0.47	-0.68	-0.61	0.54	0.43	-0.78	0.81	0.59	0.46		0.44	0.37	0.55	-0.66	0.45
Long Term Investments	0.72	0.71	0.76	0.78	0.31	0.66	0.69	0.63	0.61	0.75	0.34	0.79	-0.76	-0.25	0.75	0.79	-0.71	0.33	0.79	0.75	0.44		0.66	0.82	-0.25	0.71
Short Long Term Debt	0.8	0.79	0.62	0.81	0.08	0.76	0.79	0.82	0.8	0.9	0.17	0.74	-0.68	-0.37	0.79	0.58	-0.69	0.32	0.85	0.62	0.37	0.66		0.74	-0.32	0.95
Net Invested Capital	0.91	0.88	0.94	0.95	0.51	0.8	0.92	0.78	0.83	0.74	0.36	0.96	-0.91	-0.3	0.95	0.94	-0.93	0.41	0.94	0.85	0.55	0.82	0.74		-0.58	0.79
Net Working Capital	-0.64	-0.62	-0.56	-0.66	-0.6	-0.64	-0.67	-0.58	-0.49	-0.22	-0.36	-0.54	0.78	0.36	-0.68	-0.63	0.66	-0.5	-0.47	-0.71	-0.66	-0.25	-0.32	-0.58		-0.45
Capital Stock	0.81	0.79	0.65	0.84	0.17	0.76	0.81	0.81	0.81	0.85	0.28	0.74	-0.74	-0.37	0.81	0.68	-0.73	0.33	0.85	0.73	0.45	0.71	0.95	0.79	-0.45

Click cells to compare fundamentals

Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.

Competition

Predict Amedisys

Retained Earnings Over Time

Based on the latest financial disclosure, Amedisys has a Retained Earnings of 747.92 M. This is 19.7% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The retained earnings for all United States stocks is 91.98% higher than that of the company.

Amedisys Retained Earnings Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amedisys' direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Amedisys could also be used in its relative valuation, which is a method of valuing Amedisys by comparing valuation metrics of similar companies.

Amedisys is currently under evaluation in retained earnings category among related companies.

Amedisys Fundamentals

	Return On Equity	-0.0098
	Return On Asset	0.0598
	Profit Margin	(0) %
	Operating Margin	0.08 %
	Current Valuation	3.38 B
	Shares Outstanding	32.67 M
	Shares Owned By Insiders	2.26 %
	Shares Owned By Institutions	96.17 %
	Number Of Shares Shorted	2.49 M
	Price To Earning	15.03 X
	Price To Book	2.81 X
	Price To Sales	1.34 X
	Revenue	2.24 B
	Gross Profit	453.98 M
	EBITDA	216.91 M
	Net Income	(9.75 M)
	Cash And Equivalents	17.96 M
	Cash Per Share	0.55 X
	Total Debt	487.21 M
	Debt To Equity	0.53 %
	Current Ratio	1.06 X
	Book Value Per Share	32.65 X
	Cash Flow From Operations	137.19 M
	Short Ratio	7.11 X
	Earnings Per Share	(0.30) X
	Price To Earnings To Growth	1.35 X
	Target Price	97.78
	Number Of Employees	19 K
	Beta	0.86
	Market Capitalization	2.97 B
	Total Asset	2.06 B
	Retained Earnings	747.92 M
	Working Capital	23.21 M
	Current Asset	175.26 M
	Current Liabilities	175.19 M
	Net Asset	2.06 B

About Amedisys Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Amedisys's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amedisys using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amedisys based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Amedisys in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Amedisys' short interest history, or implied volatility extrapolated from Amedisys options trading.

Pair Trading with Amedisys

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amedisys position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amedisys will appreciate offsetting losses from the drop in the long position's value.

Moving together with Amedisys Stock

0.91

EMBC

Embecta Corp Financial Report 10th of May 2024

Pair Corr

Moving against Amedisys Stock

0.77	HIMS	Hims Hers Health Financial Report 13th of May 2024	Pair Corr
0.66	ELMD	Electromed	Pair Corr
0.54	HOLX	Hologic Financial Report 6th of May 2024	Pair Corr
0.53	BAX	Baxter International Financial Report 25th of April 2024	Pair Corr
0.51	ALC	Alcon AG Financial Report 14th of May 2024	Pair Corr

The ability to find closely correlated positions to Amedisys could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amedisys when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amedisys - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amedisys to buy it.

The correlation of Amedisys is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amedisys moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amedisys moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Amedisys can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Amedisys is a strong investment it is important to analyze Amedisys' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Amedisys' future performance. For an informed investment choice regarding Amedisys Stock, refer to the following important reports:

How To Invest In Amedisys

Details

Is Amedisys Stock a good investment?

Details

What is Amedisys' Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Amedisys Piotroski F Score and Amedisys Altman Z Score analysis.

For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.

Note that the Amedisys information on this page should be used as a complementary analysis to other Amedisys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for Amedisys Stock analysis

When running Amedisys' price analysis, check to measure Amedisys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amedisys is operating at the current time. Most of Amedisys' value examination focuses on studying past and present price action to predict the probability of Amedisys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amedisys' price. Additionally, you may evaluate how the addition of Amedisys to your portfolios can decrease your overall portfolio volatility.

	Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
	Commodity Directory Find actively traded commodities issued by global exchanges
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes

Is Amedisys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amedisys. If investors know Amedisys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amedisys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.40)

Earnings Share

(0.30)

Revenue Per Share

68.603

Quarterly Revenue Growth

0.016

Return On Assets

0.0598

The market value of Amedisys is measured differently than its book value, which is the value of Amedisys that is recorded on the company's balance sheet. Investors also form their own opinion of Amedisys' value that differs from its market value or its book value, called intrinsic value, which is Amedisys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amedisys' market value can be influenced by many factors that don't directly affect Amedisys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Amedisys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amedisys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amedisys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Amedisys Stock Retained Earnings

Amedisys Company Retained Earnings Analysis

Retained Earnings

Beginning RE + Income

-

Dividends

Current Amedisys Retained Earnings

Amedisys Retained Earnings Driver Correlations

Amedisys Retained Earnings Peer Comparison

Amedisys Fundamentals

About Amedisys Fundamental Analysis

Pair Trading with Amedisys

Moving together with Amedisys Stock

Moving against Amedisys Stock

Complementary Tools for Amedisys Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY